Next Article in Journal
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion
Next Article in Special Issue
Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (RotarixTM) Immunogenicity among Infants in Zambia
Previous Article in Journal
A Meta-Analysis on the Association between Peptic Ulcer Disease and COVID-19 Severity
Previous Article in Special Issue
Evaluation of ROTARIX® Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial
 
 
Article

Article Versions Notes

Vaccines 2023, 11(6), 1088; https://doi.org/10.3390/vaccines11061088
Action Date Notes Link
article xml file uploaded 11 June 2023 11:54 CEST Original file -
article xml uploaded. 11 June 2023 11:54 CEST Update https://www.mdpi.com/2076-393X/11/6/1088/xml
article pdf uploaded. 11 June 2023 11:54 CEST Version of Record https://www.mdpi.com/2076-393X/11/6/1088/pdf
article supplementary file uploaded. 11 June 2023 11:54 CEST - https://www.mdpi.com/2076-393X/11/6/1088#supplementary
article html file updated 11 June 2023 11:56 CEST Original file -
article html file updated 20 June 2023 21:54 CEST Update https://www.mdpi.com/2076-393X/11/6/1088/html
Back to TopTop